BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17257427)

  • 1. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.
    Yaar M; Eller MS; Panova I; Kubera J; Wee LH; Cowan KH; Gilchrest BA
    Breast Cancer Res; 2007; 9(1):R13. PubMed ID: 17257427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
    Li GZ; Eller MS; Hanna K; Gilchrest BA
    Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere-based DNA damage responses: a new approach to melanoma.
    Puri N; Eller MS; Byers HR; Dykstra S; Kubera J; Gilchrest BA
    FASEB J; 2004 Sep; 18(12):1373-81. PubMed ID: 15333580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy.
    Crescenzi E; Palumbo G; de Boer J; Brady HJ
    Clin Cancer Res; 2008 Mar; 14(6):1877-87. PubMed ID: 18347191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
    Aoki H; Iwado E; Eller MS; Kondo Y; Fujiwara K; Li GZ; Hess KR; Siwak DR; Sawaya R; Mills GB; Gilchrest BA; Kondo S
    FASEB J; 2007 Sep; 21(11):2918-30. PubMed ID: 17449721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review.
    Vaziri H
    Biochemistry (Mosc); 1997 Nov; 62(11):1306-10. PubMed ID: 9467855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
    Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells.
    Ohashi N; Yaar M; Eller MS; Truzzi F; Gilchrest BA
    J Cell Physiol; 2007 Mar; 210(3):582-95. PubMed ID: 17133364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drug amooranin induces apoptosis through caspase activity in human breast carcinoma cell lines.
    Rabi T; Ramachandran C; Fonseca HB; Nair RP; Alamo A; Melnick SJ; Escalon E
    Breast Cancer Res Treat; 2003 Aug; 80(3):321-30. PubMed ID: 14503804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
    Seth P; Katayose D; Li Z; Kim M; Wersto R; Craig C; Shanmugam N; Ohri E; Mudahar B; Rakkar AN; Kodali P; Cowan K
    Cancer Gene Ther; 1997; 4(6):383-90. PubMed ID: 9408609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ssDNA fragments induce cell senescence by telomere uncapping.
    Tsolou A; Passos JF; Nelson G; Arai Y; Zglinicki Tv
    Exp Gerontol; 2008 Oct; 43(10):892-9. PubMed ID: 18778766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
    Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA
    Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin.
    Di X; Shiu RP; Newsham IF; Gewirtz DA
    Biochem Pharmacol; 2009 Apr; 77(7):1139-50. PubMed ID: 19185564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
    Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF-7.
    Yu JH; Cui Q; Jiang YY; Yang W; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2007 Dec; 28(12):1975-83. PubMed ID: 18031612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells.
    Cho MY; Park SY; Park S; Lee YR; Kwak MK; Kim JA
    Arch Pharm Res; 2012 May; 35(5):911-9. PubMed ID: 22644859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.